Introduction Severe acute hepatitis (SAH) is defined by a severe inflammation of
hepatocytes in the liver parenchyma which can lead to an acute liver failure, a clinical …

Hepatitis C virus (HCV) cure after all-oral direct-acting antiviral (DAA) therapy greatly
improves the liver and immune system. We aimed to assess the impact of this HCV …

Altered immune parameters associated with hepatitis C virus (HCV) genotype 1b infection
and their correlation with virus eradication in direct‐acting antivirals (DAA)‐treated patients …

Purpose To identify potential risk factors for herpes zoster infection in type 2 diabetes
mellitus in southeast Chinese population. Patients and Methods We built a model involving …

Background We performed a case-series analysis of reactivation of herpesvirus in patients
with hepatitis C virus (HCV) infection treated with direct-acting antiviral (DAA) agents …

Little is known about the association between glycemic status and herpes zoster. The aim of
this study was to evaluate whether glycemic status, including both high and low hemoglobin …

Efforts toward eradicating the Hepatitis C virus (HCV) have advanced rapidly, due to the
development of direct-acting antivirals (DAAs), especially with the appearance of pan …

Background: Hepatitis C virus (HCV) affects approximately 2-2.5% of the global population.
In Egypt, the prevalence was reported at 7% in 2015. Over recent years, new direct-acting …

Objective: The co-infection of HCV/CMV may accelerate the progression of liver diseases
and worsen responsiveness to IFN treatment. The Direct-acting antiviral agents (DAAs) …

Background and Aims Recent case series and retrospective studies have raised concerns
that patients who receive direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) …